Innovation for Healthier Eyes

Bring excellence and precision to ophthalmology by providing improved diagnostic and therapeutic choices for eye care.

Envisioning Better Health

We focus on investigating the mechanisms of eye disorders with unmet medical needs through biomarker research, and on developing diagnostics and therapeutics to improve vision and eye care.

Founded in 2015, Seinda Biomedical Corp. is a specialized point-of-care diagnostics company that brings together experts from the biomedical, pharmaceutical, immunology, and ophthalmology sectors to pioneer improved choices for eye care.

Diagnostics

Founded in 2015, Seinda Biomedical Corp. is a specialized point-of-care diagnostics company that brings together experts from the biomedical, pharmaceutical eye care.

Therapeutics

Founded in 2015, Seinda Biomedical Corp. is a specialized point-of-care diagnostics company that brings together experts from the biomedical, pharmaceutical eye care.

Biomarker

Founded in 2015, Seinda Biomedical Corp. is a specialized point-of-care diagnostics company that brings together experts from the biomedical, pharmaceutical eye care.

Envisioning Better Health

Solutions

We leverage our core expertise in the molecular mechanisms of different ophthalmic disorders for annotative diagnostic and therapeutic development.

Our new drug therapies are based on our research on underlying mechanisms of ocular disorders, for precise treatment solutions.

We leverage our core expertise in the molecular mechanisms of different ophthalmic disorders for annotative diagnostic and therapeutic development.

Diagnostic Equipment

Designed for ophthalmic point-of-care applications

i-ImmunDx™ Platform

Designed for ophthalmic point-of-care applications

Seinda’s proprietary i-ImmunDx™ platform is specifically designed for ophthalmic point-of-care applications. The i-ImmunDx™ platform is the basis for the development of Seinda’s series of point-of-care testing (POCT) products. Our line of POCT products help facilitate clinical diagnosis, aid treatment selection, and monitor disease status.